A,
Inpp5dfl/fl/Cx3xr1CreER+
mice were crossed with the amyloid-depositing
APPKM670/671NL/PSEN1Δexon9
mouse model of Alzheimer’s disease (AD) to obtain either heterozygous
PSAPP mice, that is,
PSAPP/Inpp5dfl/fl/Cx3xr1CreER+
(PSAPP) or wild-type littermates
Inpp5dfl/fl/Cx3xr1CreER+
(WT). At age 3 months, male and female mice of both genotypes received daily
injections of tamoxifen (TAM) or corn oil (CO) for 5 days before aging to the
experimental timepoint of ages 6 to 6.5 months. B, Western blot of hippocampal
tissue at 6 to 6.5 months of age using anti-SHIP1 (D1163) antibody normalized to
β-actin. Quantification in (C). D, Representative images from 6-month
PSAPP-TAM (top) and PSAPP-CO (bottom) mice stained with 6E10 (amyloid, red) or
anti-IBA1 (myeloid cells, green). Scale bar = 500 μm. E,
Relative fold change of 6E10-immunoreactive area in the hippocampi of male and
female PSAPP-CO and PSAPP-TAM mice (n = 7 mice per group). F,
Relative fold change of plaque numbers per mm2 in the hippocampi of
male and female PSAPP-CO and PSAPP-TAM mice (n = 7 mice per
group). For both (F) and (G), fold changes were calculated separately for each
sex. G, Cumulative frequency of plaque areas of male and female PSAPP-CO and
PSAPP-TAM mice (plaques from 8 mice per group). H, Quantification of number of
IBA1+ microglia and (I) area of IBA1+ area in
hippocampus from WT-CO, WT-TAM, PSAPP-CO and PSAPP-TAM (n = 6
to 7 mice per group). J, Confocal Z-stack and orthogonal views of plaques from
PSAPP-TAM and PSAPP-CO mice. Quantification of plaque-associated microglia shown
in (K). Scale bar = 50 μm. L, Quantification of plaque
coverage by microglia (% area of IBA1 staining overlapping area of
6E10+ plaques) for PSAPP-CO and PSAPP-TAM (n = 7
mice per group). Bar graphs represent the mean and error bars represent standard
error of the mean. P-values were calculated using unpaired t
test (B, E, F, K, L), one-way analysis of variance with Tukey’s multiple
comparison (C H, I), or by a Kolmogorov–Smirnov test (G)